A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia
NCT01606228
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
188
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Paliperidone ER
Sponsor
Janssen Pharmaceutica